详情页 - 聚合机构库演示平台

资源类型：

文章类型：

作者：

Li, Chunrui[1] *

; Wang, Di[2] ; Song, Yongping[3,4] ; Li, Jianyong[5] ; Huang, He[6,7] ; Chen, Bing[8] ; Liu, Jing[9] ; Hu, Kai[10] ; Ren, Hanyun[11] ; Zhang, Xi[12] ; Li, Zhenyu[13] ; Zou, Dehui[14,15] ; Yin, Qingsong[16] ; Chen, Lijuan[17] ; Hu, Yongxian[18] ; Xu, Yong[19] ; Cheng, Qian[20] ; Guo, Yuelu[21] ; Dong, Yujun[11] ; Gao, Li[22,23] ; Xu, Aining[24] ; Cai, Songbai[25] ; Wang, Wen[26] ; Wu, Ming[25] ; Wang, Jue[1]

; Chen, Liting[27]

; Zhou, Jianfeng[1]

; Qiu, Lugui[14,15] ;

单位： [1]Huazhong Univ Sci & Technol, Tongji Hosp, Dept Hematol, Tongji Med Coll, Wuhan, Peoples R China [2]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China [3]Zhengzhou Univ, Dept Hematol, Affiliated Canc Hosp, Zhengzhou, Peoples R China [4]Henan Canc Hosp, Zhengzhou, Peoples R China [5]Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, Dept Hematol, Jiangsu Prov Hosp,Pukou CLL Ctr,Affiliated Hosp 1, Nanjing, Peoples R China [6]Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou, Peoples R China [7]Zhejiang Univ, Inst Hematol, Hangzhou, Peoples R China [8]Nanjing Univ, Affiliated Nanjing Drum Tower Hosp, Dept Hematol, Med Sch, Nanjing, Peoples R China [9]Cent South Univ, Xiangya Hosp 3, Dept Hematol, Changsha, Hunan, Peoples R China [10]Beijing Boren Hosp, Dept Hematol, Beijing, Peoples R China [11]Peking Univ First Hosp, Dept Hematol, Beijing, Peoples R China [12]Army Med Univ, Xinqiao Hosp, Med Ctr Hematol, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China [13]Xuzhou Med Univ, Dept Hematol, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China [14]Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Natl Clin Res Ctr Blood Dis, Blood Dis Hosp, Tianjin, Peoples R China [15]Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol, Tianjin, Peoples R China [16]Zhengzhou Univ, Henan Canc Hosp, Affiliated Canc Hosp, Zhengzhou, Peoples R China [17]Nanjing Med Univ, Dept Hematol, Affiliated Hosp 1, Nanjing, Peoples R China [18]Zhejiang Univ, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Sch Med, Hangzhou, Peoples R China [19]Nanjing Univ Med Sch, Affiliated Nanjing Drum Tower Hosp, Dept Hematol, Nanjing, Peoples R China [20]Cent South Univ, Dept Hematol, Xiangya Hosp 3, Changsha, Peoples R China [21]Beijing Boren Hosp, Beijing, Peoples R China [22]Army Med Univ, Xinqiao Hosp, Dept Hematol, Chongqing, Peoples R China [23]Army Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China [24]Nanjing IASO Biotherapeut Ltd, Nanjing, Jiangsu, Peoples R China [25]Nanjing IASO Biotherapeut Ltd, Shanghai, Peoples R China [26]Nanjing IASO Biotherapeut Ltd, Nanjing, Peoples R China [27]Huazhong Univ Sci, Tongji Med Coll, Dept Hematol, Tongji Hosp, Wuhan, Peoples R China

出处：

DOI：

ISSN：

语种：

被引次数：

WOS：

中科院(CAS)分区：

出版当年[2020]版：

大类 | 1 区

医学

小类 | 1 区血液学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区血液学

JCR分区：

出版当年[2019]版：

Q1 HEMATOLOGY

最新[2024]版：

Q1 HEMATOLOGY

第一作者：

第一作者单位： [1]Huazhong Univ Sci & Technol, Tongji Hosp, Dept Hematol, Tongji Med Coll, Wuhan, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

A Phase 1/2 Study of a Novel Fully Human B-Cell Maturation Antigen-Specific CAR T Cells (CT103A) in Patients with Relapsed and/or Refractory Multiple Myeloma

文献详情